# Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

> **NCT02161965** · PHASE4 · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 51 (actual)

## Conditions studied

- Permanent Atrial Fibrillation
- Venous Thrombosis
- Pulmonary Embolism
- Anticoagulation Treatment at Least > or = to 12-month

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Fluindione
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT02161965
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-21
- **Primary completion:** 2016-12-31
- **Final completion:** 2018-02-16
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02161965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02161965, "Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02161965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*